MET-dependent solid tumours — molecular diagnosis and targeted therapy
Nature Reviews Clinical Oncology, Published online: 08 June 2020; doi:10.1038/s41571-020-0377-zTherapies targeting MET-overexpressing cancers have limited efficacy. However, owing to advances in detection methods, therapies targeting MET-dependent tumours harbouring MET amplifications, activating mutations or fusions are emerging. In this review, the authors describe emerging data on this new class of targeted therapies.
Source: Nature Reviews Clinical Oncology - Category: Cancer & Oncology Authors: Robin Guo Jia Luo Jason Chang Natasha Rekhtman Maria Arcila Alexander Drilon Source Type: research
More News: Cancer | Cancer & Oncology